Mesoblast Financials - Benzinga

Mesoblast Ltd

MESONASDAQ

Trade with Public

Trade with Public

$15.94

0.322.05%

At close: Aug 7, 5:00 PM EST

$15.69

-0.25-1.57%

After Hours: 9:15 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Mesoblast Financials

Mesoblast (MESO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Mesoblast H1 EPS $(0.03) Beats $(0.20) Estimate, Sales $51.342M Miss $72.000M Estimate

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.20) by 84.5 percent. This is a 99.26 percent increase over losses of $(4.20) per share from the same

Benzinga Newsdesk

Earnings Scheduled For February 26, 2026

Benzinga Insights

What's Next: Mesoblast's Earnings Preview

Benzinga Insights

PRO
Mesoblast FY EPS $(0.09) Misses $(0.05) Estimate, Sales $17.20M Up From $5.90M YoY

Mesoblast (NASDAQ:MESO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.05) by 70 percent. This is a 99.05 percent increase over losses of $(8.91) per share from the same

Benzinga Newsdesk

Earnings Scheduled For August 28, 2025

Benzinga Insights

Examining the Future: Mesoblast's Earnings Outlook

Benzinga Insights